31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
As expected, the Fed kept interest rates unchanged on Wednesday while also signaling that “they wou...
Read More >
Markets started 2020 witnessing the detrimental impact of the COVID-19 pandemic on the global econom...
Read More >
Maryland employers are now prohibited from enforcing non-compete agreements against employees earnin...
Read More >
Under the U.S. Sentencing Guidelines, the Board must exercise reasonable oversight on the effectiven...
Read More >
Dear YouDig?, We are an old school company. We admit that we have not adopted technology as fast as...
Read More >
On July 29th OSHA submitted a draft Request for Information (RFI) to the Office of Management and Bu...
Read More >